Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan/HCTZ in Mild to Moderate Essential Hypertension
NCT01431508Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of losartan and hydrochlorothiazide in essential hypertension, sponsored by Organon & Co. Primary endpoint: Mean Change From Baseline in Trough Sitting Diastolic Blood Pressure at 12 weeks. Started Aug 2007; status: completed.
02
Drugs
losartanhydrochlorothiazide
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01431508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01431508.